Table 1.
Cav-1 interactions with viral proteins
Virus family (-viridae) |
Virus | Protein | Protein function | Type of interaction with protein partner | Type of interaction with Cav-1 | Reference |
---|---|---|---|---|---|---|
Retro | HIV-1 | gp41 | Transmembrane, fusion | Binding to CBD in HIV-1, but not HIV-2 or SIV | Binding to CSD* | (Benferhat et al., 2008; Hovanessian et al., 2004) |
HIV-1 | gp41 | Transmembrane, fusion | Binding to six-helix bundle | Binding to CSD | (Huang et al., 2007) | |
HIV-1 | Not known | Not known | Cav-1 membrane insertion domain | (Llano et al., 2002) | ||
MLV-amphotropic, ecotropic | MA-Gag | Matrix, associates with membranes, link between capsid, plasma membrane, and viral membrane proteins | Binding mediated by a CBD in MA, interaction locates MA to lipid rafts domains in PM | Interaction with CSD*† | (Beer and Wirth, 2004; Yu et al., 2006) | |
Corona | SARS | ORF3a | Not known, Functioning in Golgi localization? | Binding to several CBDs | Not known, interaction with CSD likely | (Padhan et al., 2007) |
Orthomyxo | Influenza A virus human | M2 | Early phase: Ion channel, viroporin Late Phase: matrix, virus assembly and budding |
Binding. Protein regions presumably CBD aa47-55 | Binding to CSD*† Binding to CSD‡ |
This investigation Zou et al. 2009 |
Influenza A virus human | HA | Receptor binding | Colocalization in perinuclear regions | (Scheiffele et al., 1998) | ||
Paramyxo | RSV | ? | ? | Colocalization with internal viral filaments, colocalization at lipid rafts | Binding not specified, redistribution of Cav-1 after phosphorylation | (Brown et al., 2002; Brown, Rixon, and Sugrue, 2002; McDonald et al., 2004) |
Reo | Rotavirus | NSP4 | Ion channel formation, ER and caveolae localization, important for morphogenesis | Binding aa114-135 (enterotoxic peptide) amphipatic helix at the C-terminus | Binding and colocalization, 2 independent binding sites at the N-terminus (aa2-22)and C-terminus (aa161-178) identified, influence on localization or transport? | (Mir et al., 2007; Parr et al., 2006; Storey et al., 2007) |
*Pull-down experiments with biotinylated CBD-peptides
†Co-immunoprecipitation
‡ ELISA